MedPath

SUSTIVA 200MG

SUSTIVA 200MG

Discontinued
DIN Number

02239888

Drug Class

Human

Market Date

Mar 25, 1999

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02239888
AIG Number0137031003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AG03 EFAVIRENZ
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:18.08.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

EFAVIRENZActive
Strength: 200 MG
Monograph: EFAVIRENZ

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.